A placebo-managed RCT displays that SXC, a patent medication, features noninferior BP-lowering and may well lower cholesterol. A Chinese organic system known as Songling Xuemaikang capsule (SXC) is noninferior to losartan when it arrives to decreasing blood tension among individuals with moderate hypertension, outcomes of a new randomized demo exhibit. […]
Sunday, Nov 1, 2026
Breaking News